3,3′-diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1

International Journal of Cancer

Volumn 129, Issue 7, 2011, Pages 1781-1791

  Ahmad, Aamir ^a   Ali, Shadan ^a   Wang, Zhiwei ^a   Ali, Ashhar S ^a   Sethi, Seema ^a   Sakr, Wael A ^a   Raz, Avraham ^a   Rahman, K M Wahidur ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; DIM; FoxM1; Taxotere

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3,3' DIINDOLYLMETHANE; BETA ACTIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 2; DOCETAXEL; FORKHEAD BOX M1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; GELATINASE B; MESSENGER RNA; PROTEIN P21; PROTEIN P27; SMALL INTERFERING RNA; SURVIVIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; VASCULOTROPIN; 3,3'-DIINDOLYLMETHANE; FOXM1 PROTEIN, HUMAN; INDOLE DERIVATIVE; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIZATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECT; DRUG SCREENING; GENETICS; HUMAN; METABOLISM; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INDOLES; MICE; MICE, NUDE; TAXOIDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960908917     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25839     Document Type: Article

References (50)

1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldon W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK, eds. SEER Cancer Statistics Review, 1975-2007. USA: National Cancer Institute, 2010.
2. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Bektas N, Haaf A, Veeck J, Wild PJ, Luscher-Firzlaff J, Hartmann A, Knuchel R, Dahl E,. Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer 2008; 8: 1-9.
4. Madureira PA, Varshochi R, Constantinidou D, Francis RE, Coombes RC, Yao KM, Lam EW,. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem 2006; 281: 25167-76. (Pubitemid 44401903)
5. Kalin TV, Wang IC, Ackerson TJ, Major ML, Detrisac CJ, Kalinichenko VV, Lyubimov A, Costa RH,. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 2006; 66: 1712-20. (Pubitemid 43259956)
6. Yoshida Y, Wang IC, Yoder HM, Davidson NO, Costa RH,. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology 2007; 132: 1420-31. (Pubitemid 46627572)
7. Penzo M, Massa PE, Olivotto E, Bianchi F, Borzi RM, Hanidu A, Li X, Li J, Marcu KB,. Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. J Cell Physiol 2009; 218: 215-27.
8. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, Michalopoulos G, Becich M, Monzon FA,. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007; 7: 1-21.
9. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV,. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006; 66: 2153-61.
10. Wang X, Bhattacharyya D, Dennewitz MB, Kalinichenko VV, Zhou Y, Lepe R, Costa RH,. Rapid hepatocyte nuclear translocation of the Forkhead Box M1B (FoxM1B) transcription factor caused a transient increase in size of regenerating transgenic hepatocytes. Gene Expr 2003; 11: 149-62. (Pubitemid 37516648)
11. Wang X, Hung NJ, Costa RH,. Earlier expression of the transcription factor HFH-11B diminishes induction of p21(CIP1/WAF1) levels and accelerates mouse hepatocyte entry into S-phase following carbon tetrachloride liver injury. Hepatology 2001; 33: 1404-14. (Pubitemid 32496977)
12. Wang X, Kiyokawa H, Dennewitz MB, Costa RH,. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci USA 2002; 99: 16881-6. (Pubitemid 36034067)
13. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV, Costa RH, Raychaudhuri P, Tyner AL, Lau LF,. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 2008; 283: 20770-8.
14. Wonsey DR, Follettie MT,. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 2005; 65: 5181-9. (Pubitemid 40827327)
15. Wang X, Krupczak-Hollis K, Tan Y, Dennewitz MB, Adami GR, Costa RH,. Increased hepatic Forkhead Box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J Biol Chem 2002; 277: 44310-16. (Pubitemid 36157865)
16. Liu M, Dai B, Kang SH, Ban K, Huang FJ, Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, Sawaya R, Huang S,. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 2006; 66: 3593-602.
17. Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM, Dennewitz MB, Shin B, Datta A, Raychaudhuri P, Costa RH,. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 2004; 18: 830-50. (Pubitemid 38480894)
18. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG,. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 2002; 62: 4773-80.
19. Adami GR, Ye H,. Future roles for FoxM1 inhibitors in cancer treatments. Future Oncol 2007; 3: 1-3.
20. Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH,. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat 2010; 122: 337-46.
21. Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A,. Inactivation of NF-kB by 3,3′-diindolylmethane (DIM) contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol Cancer Ther 2007; 6: 1-9.
22. Rahman KM, Banerjee S, Ali S, Ahmad A, Wang Z, Kong D, Sakr WA,. 3,3′-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Cancer Res 2009; 69: 4468-75.
23. Rahman KM, Sarkar FH,. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3′-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 2005; 65: 364-71. (Pubitemid 40070830)
24. Abdelrahim M, Newman K, Vanderlaag K, Samudio I, Safe S,. 3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006; 27: 717-28.
25. Kassie F, Anderson LB, Scherber R, Yu N, Lahti D, Upadhyaya P, Hecht SS,. Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. Cancer Res 2007; 67: 6502-11. (Pubitemid 47037536)
26. Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW,. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol Cancer Ther 2008; 7: 2022-32.
27. McGovern UB, Francis RE, Peck B, Guest SK, Wang J, Myatt SS, Krol J, Kwok JM, Polychronis A, Coombes RC, Lam EW,. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mol Cancer Ther 2009; 8: 582-91.
28. Ferrara N,. History of discovery: vascular endothelial growth factor. Arterioscler Thromb Vasc Biol, 2009; 29: 789-91.
29. Wan R, Mo Y, Zhang X, Chien S, Tollerud DJ, Zhang Q,. Matrix metalloproteinase-2 and -9 are induced differently by metal nanoparticles in human monocytes: the role of oxidative stress and protein tyrosine kinase activation. Toxicol Appl Pharmacol 2008; 233: 276-85. (Pubitemid 50306576)
30. Rahman KM, Sarkar FH, Banerjee S, Wang Z, Liao DJ, Hong X, Sarkar NH,. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol Cancer Ther 2006; 5: 2747-56. (Pubitemid 44849001)
31. Rahman KM, Li Y, Sarkar FH,. Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 2004; 48: 84-94. (Pubitemid 38823550)
32. Ye H, Holterman AX, Yoo KW, Franks RR, Costa RH,. Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase. Mol Cell Biol 1999; 19: 8570-80. (Pubitemid 30414050)
33. Dai B, Kang SH, Gong W, Liu M, Aldape KD, Sawaya R, Huang S,. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 2007; 26: 6212-19. (Pubitemid 47414378)
34. Zhang Y, Zhang N, Dai B, Liu M, Sawaya R, Xie K, Huang S,. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 2008; 68: 8733-42.
35. Gusarova GA, Wang IC, Major ML, Kalinichenko VV, Ackerson T, Petrovic V, Costa RH,. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J Clin Invest 2007; 117: 99-111. (Pubitemid 46048457)
36. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH,. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 2005; 7: 126-36. (Pubitemid 40268127)
37. Radhakrishnan SK, Gartel AL,. FOXM1: the Achilles' heel of cancer? Nat Rev Cancer 2008; 8: c1; author reply c2.
38. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R,. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 2004; 6: 744-50. (Pubitemid 40041492)
39. Li Y, Hong X, Hussain M, Sarkar SH, Li R, Sarkar FH,. Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol Cancer Ther 2005; 4: 389-98. (Pubitemid 40443924)
40. Costa RH,. FoxM1 dances with mitosis. Nat Cell Biol 2005; 7: 108-10. (Pubitemid 40268125)
41. Li Y, Li X, Sarkar FH,. Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. J Nutr 2003; 133: 1011-19. (Pubitemid 36407118)
42. Obaya AJ, Sedivy JM,. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci 2002; 59: 126-42. (Pubitemid 34117361)
43. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S, Lee YY, Bartram CR,. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 1995; 55: 2266-9.
44. Leung KC, Hsin MK, Chan JS, Yip JH, Li M, Leung BC, Mok TS, Warner TD, Underwood MJ, Chen GG,. Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27. Exp Cell Res 2009; 315: 2974-81.
45. Hong C, Kim HA, Firestone GL, Bjeldanes LF,. 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002; 23: 1297-305.
46. Song J, Salek-Ardakani S, So T, Croft M,. The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes. Nat Immunol 2007; 8: 64-73. (Pubitemid 46242360)
47. John A, Tuszynski G,. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7: 14-23. (Pubitemid 32591662)
48. Curran S, Murray GI,. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36: 1621-30. (Pubitemid 30616366)
49. Hicklin DJ, Ellis LM,. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011-27. (Pubitemid 46202320)
50. Hatake K, Tokudome N, Ito Y,. Next generation molecular targeted agents for breast cancer: focus on EGFR and VEGFR pathways. Breast Cancer 2007; 14: 132-49.